Kimberly-Clark (KMB)
Market Price (4/9/2026): $96.8 | Market Cap: $32.1 BilSector: Consumer Staples | Industry: Household Products
Kimberly-Clark (KMB)
Market Price (4/9/2026): $96.8Market Cap: $32.1 BilSector: Consumer StaplesIndustry: Household Products
Investment Highlights Why It Matters Detailed financial logic regarding cash flow yields vs trend-riding momentum.
Attractive yieldTotal YieldTotal Yield = Earnings Yield + Dividend Yield, Earnings Yield = Net Income / Market Cap Dividend Yield = Total Dividends / Market Cap is 11%, Dividend Yield is 5.2%, ERPEquity Risk Premium (ERP) = Total Yield - Risk Free Rate, Reflects the premium above risk free assets offered by the investment. is 7.4%, FCF Yield is 5.1% Attractive cash flow generationCFO/Rev LTMCash Flow from Operations / Revenue (Sales), Last Twelve Months (LTM) is 16%, CFO LTM is 2.8 Bil Stock buyback supportStock Buyback 3Y Total is 1.5 Bil Low stock price volatilityVol 12M is 25% Megatrend and thematic driversMegatrends include Aging Population & Chronic Disease, Sustainable Consumption, and E-commerce & DTC Adoption. Themes include Geriatric Care, Show more. | Weak multi-year price returns2Y Excs Rtn is -47%, 3Y Excs Rtn is -84% Meaningful short interestShort Interest % of Basic SharesShort Interest % of Basic Shares = (Short Interest Quantity) / (Basic Shares Outstanding). A high fraction of short interest can indicate potential risk of a short squeeze. is 12% | Weak revenue growthRev Chg LTMRevenue Change % Last Twelve Months (LTM) is -2.2%, Rev Chg 3Y AvgRevenue Change % averaged over trailing 3 years is -4.8%, Rev Chg QQuarterly Revenue Change % is -0.6% Key risksKMB key risks include substantial execution and integration challenges from its strategic transformation and planned Kenvue acquisition, Show more. |
| Attractive yieldTotal YieldTotal Yield = Earnings Yield + Dividend Yield, Earnings Yield = Net Income / Market Cap Dividend Yield = Total Dividends / Market Cap is 11%, Dividend Yield is 5.2%, ERPEquity Risk Premium (ERP) = Total Yield - Risk Free Rate, Reflects the premium above risk free assets offered by the investment. is 7.4%, FCF Yield is 5.1% |
| Attractive cash flow generationCFO/Rev LTMCash Flow from Operations / Revenue (Sales), Last Twelve Months (LTM) is 16%, CFO LTM is 2.8 Bil |
| Stock buyback supportStock Buyback 3Y Total is 1.5 Bil |
| Low stock price volatilityVol 12M is 25% |
| Megatrend and thematic driversMegatrends include Aging Population & Chronic Disease, Sustainable Consumption, and E-commerce & DTC Adoption. Themes include Geriatric Care, Show more. |
| Weak multi-year price returns2Y Excs Rtn is -47%, 3Y Excs Rtn is -84% |
| Meaningful short interestShort Interest % of Basic SharesShort Interest % of Basic Shares = (Short Interest Quantity) / (Basic Shares Outstanding). A high fraction of short interest can indicate potential risk of a short squeeze. is 12% |
| Weak revenue growthRev Chg LTMRevenue Change % Last Twelve Months (LTM) is -2.2%, Rev Chg 3Y AvgRevenue Change % averaged over trailing 3 years is -4.8%, Rev Chg QQuarterly Revenue Change % is -0.6% |
| Key risksKMB key risks include substantial execution and integration challenges from its strategic transformation and planned Kenvue acquisition, Show more. |
Qualitative Assessment
AI Analysis | Feedback
1. Mixed Q4 2025 Financial Results and Flat 2026 Adjusted EPS Outlook. Kimberly-Clark reported Q4 2025 net sales of $4.08 billion, a 0.6% decline year-over-year, falling short of analyst estimates of $4.11 billion. This revenue miss was partly due to a 2.5% negative impact from exiting the company's private label diaper business in the U.S.. More critically, the company's 2026 outlook projected adjusted earnings per share (EPS) to be flat on a constant-currency basis, largely attributable to a reduction in income from discontinued operations.
2. Widespread Analyst Downgrades and Price Target Reductions. Throughout the period, several analyst firms revised their ratings and lowered price targets for Kimberly-Clark. For instance, UBS decreased its price target by 18.94% from $132.00 to $107.00 in January 2026, while Piper Sandler lowered its target by 14.29% from $133.00 to $114.00 in March 2026. The consensus among many analysts shifted to a "Hold" rating, reflecting caution regarding the company's prospects.
Show more
Stock Movement Drivers
Fundamental Drivers
The -2.7% change in KMB stock from 12/31/2025 to 4/8/2026 was primarily driven by a -5.1% change in the company's P/E Multiple.| (LTM values as of) | 12312025 | 4082026 | Change |
|---|---|---|---|
| Stock Price ($) | 99.66 | 97.00 | -2.7% |
| Change Contribution By: | |||
| Total Revenues ($ Mil) | 17,257 | 17,233 | -0.1% |
| Net Income Margin (%) | 11.4% | 11.7% | 2.8% |
| P/E Multiple | 16.8 | 15.9 | -5.1% |
| Shares Outstanding (Mil) | 332 | 332 | 0.0% |
| Cumulative Contribution | -2.7% |
Market Drivers
12/31/2025 to 4/8/2026| Return | Correlation | |
|---|---|---|
| KMB | -2.7% | |
| Market (SPY) | -5.4% | -5.8% |
| Sector (XLP) | 6.6% | 55.2% |
Fundamental Drivers
The -20.1% change in KMB stock from 9/30/2025 to 4/8/2026 was primarily driven by a -16.7% change in the company's Net Income Margin (%).| (LTM values as of) | 9302025 | 4082026 | Change |
|---|---|---|---|
| Stock Price ($) | 121.35 | 97.00 | -20.1% |
| Change Contribution By: | |||
| Total Revenues ($ Mil) | 17,251 | 17,233 | -0.1% |
| Net Income Margin (%) | 14.1% | 11.7% | -16.7% |
| P/E Multiple | 16.6 | 15.9 | -3.9% |
| Shares Outstanding (Mil) | 332 | 332 | 0.1% |
| Cumulative Contribution | -20.1% |
Market Drivers
9/30/2025 to 4/8/2026| Return | Correlation | |
|---|---|---|
| KMB | -20.1% | |
| Market (SPY) | -2.9% | -6.9% |
| Sector (XLP) | 6.5% | 48.4% |
Fundamental Drivers
The -28.8% change in KMB stock from 3/31/2025 to 4/8/2026 was primarily driven by a -18.8% change in the company's Net Income Margin (%).| (LTM values as of) | 3312025 | 4082026 | Change |
|---|---|---|---|
| Stock Price ($) | 136.16 | 97.00 | -28.8% |
| Change Contribution By: | |||
| Total Revenues ($ Mil) | 17,628 | 17,233 | -2.2% |
| Net Income Margin (%) | 14.4% | 11.7% | -18.8% |
| P/E Multiple | 17.8 | 15.9 | -10.5% |
| Shares Outstanding (Mil) | 333 | 332 | 0.2% |
| Cumulative Contribution | -28.8% |
Market Drivers
3/31/2025 to 4/8/2026| Return | Correlation | |
|---|---|---|
| KMB | -28.8% | |
| Market (SPY) | 16.3% | 7.4% |
| Sector (XLP) | 3.6% | 56.9% |
Fundamental Drivers
The -18.8% change in KMB stock from 3/31/2023 to 4/8/2026 was primarily driven by a -23.7% change in the company's P/E Multiple.| (LTM values as of) | 3312023 | 4082026 | Change |
|---|---|---|---|
| Stock Price ($) | 119.50 | 97.00 | -18.8% |
| Change Contribution By: | |||
| Total Revenues ($ Mil) | 20,175 | 17,233 | -14.6% |
| Net Income Margin (%) | 9.6% | 11.7% | 22.3% |
| P/E Multiple | 20.9 | 15.9 | -23.7% |
| Shares Outstanding (Mil) | 338 | 332 | 1.7% |
| Cumulative Contribution | -18.8% |
Market Drivers
3/31/2023 to 4/8/2026| Return | Correlation | |
|---|---|---|
| KMB | -18.8% | |
| Market (SPY) | 63.3% | 6.4% |
| Sector (XLP) | 19.6% | 58.8% |
Price Returns Compared
| 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | Total [1] | |
|---|---|---|---|---|---|---|---|
| Returns | |||||||
| KMB Return | 10% | -2% | -7% | 12% | -20% | -7% | -16% |
| Peers Return | 13% | -12% | 5% | 11% | -25% | 8% | -7% |
| S&P 500 Return | 27% | -19% | 24% | 23% | 16% | -3% | 76% |
Monthly Win Rates [3] | |||||||
| KMB Win Rate | 50% | 42% | 33% | 50% | 33% | 25% | |
| Peers Win Rate | 48% | 45% | 50% | 63% | 23% | 50% | |
| S&P 500 Win Rate | 75% | 42% | 67% | 75% | 67% | 50% | |
Max Drawdowns [4] | |||||||
| KMB Max Drawdown | -5% | -21% | -11% | -3% | -21% | -7% | |
| Peers Max Drawdown | -13% | -26% | -9% | -3% | -28% | -2% | |
| S&P 500 Max Drawdown | -1% | -25% | -1% | -2% | -15% | -7% | |
[1] Cumulative total returns since the beginning of 2021
[2] Peers: PG, CL, CLX, CHD, EPC. See KMB Returns vs. Peers.
[3] Win Rate = % of calendar months in which monthly returns were positive
[4] Max drawdown represents maximum peak-to-trough decline within a year
[5] 2026 data is for the year up to 4/8/2026 (YTD)
How Low Can It Go
| Event | KMB | S&P 500 |
|---|---|---|
| 2022 Inflation Shock | ||
| % Loss | -23.6% | -25.4% |
| % Gain to Breakeven | 30.9% | 34.1% |
| Time to Breakeven | 200 days | 464 days |
| 2020 Covid Pandemic | ||
| % Loss | -24.2% | -33.9% |
| % Gain to Breakeven | 32.0% | 51.3% |
| Time to Breakeven | 127 days | 148 days |
| 2018 Correction | ||
| % Loss | -27.0% | -19.8% |
| % Gain to Breakeven | 37.0% | 24.7% |
| Time to Breakeven | 415 days | 120 days |
| 2008 Global Financial Crisis | ||
| % Loss | -39.7% | -56.8% |
| % Gain to Breakeven | 65.8% | 131.3% |
| Time to Breakeven | 947 days | 1,480 days |
Compare to PG, CL, CLX, CHD, EPC
In The Past
Kimberly-Clark's stock fell -23.6% during the 2022 Inflation Shock from a high on 4/25/2022. A -23.6% loss requires a 30.9% gain to breakeven.
Preserve Wealth
Limiting losses and compounding gains is essential to preserving wealth.
Asset Allocation
Actively managed asset allocation strategies protect wealth. Learn more.
About Kimberly-Clark (KMB)
AI Analysis | Feedback
Here are a few brief analogies for Kimberly-Clark:
- Like Procter & Gamble, but primarily focused on personal hygiene products (diapers, feminine care) and consumer tissues (toilet paper, facial tissue, paper towels).
- Think of them as the Procter & Gamble of the baby and bathroom aisles.
AI Analysis | Feedback
- Personal Care Products: This segment includes disposable diapers, training pants, baby wipes, and feminine and incontinence care products sold under brands like Huggies, Kotex, and Depend.
- Consumer Tissue Products: This segment offers facial and bathroom tissues, paper towels, and napkins for household use, featuring brands such as Kleenex, Scott, and Cottonelle.
- K-C Professional Products: This segment provides wipers, tissues, towels, apparel, soaps, and sanitizers for away-from-home facilities, including brands like WypAll and Kimtech.
AI Analysis | Feedback
Kimberly-Clark Corporation primarily sells its products to other companies, which then distribute or sell these products to end-users (individuals or institutions). Its major customers are large retail chains, wholesale clubs, drugstores, distributors, and e-commerce platforms. For its K-C Professional segment, it also sells directly or through distributors to various commercial and institutional entities.
Major customer companies for Kimberly-Clark include, but are not limited to:
- Walmart Inc. (WMT)
- Target Corporation (TGT)
- Costco Wholesale Corporation (COST)
- The Kroger Co. (KR)
- CVS Health Corporation (CVS)
- Walgreens Boots Alliance, Inc. (WBA)
- Amazon.com, Inc. (AMZN)
Additionally, Kimberly-Clark sells to numerous other supermarkets, mass merchandisers, drugstores, warehouse clubs, variety and department stores, and other retail outlets globally, as well as various distributors for both household and away-from-home use products.
AI Analysis | Feedback
nullAI Analysis | Feedback
Michael Hsu, Chairman and Chief Executive Officer
Michael Hsu became Chairman of Kimberly-Clark in January 2020 and Chief Executive Officer in January 2019. He joined Kimberly-Clark in 2012, initially serving as Group President of the North American Consumer Products business, and later as President and Chief Operating Officer. Before joining Kimberly-Clark, Mr. Hsu held senior and executive leadership roles at Kraft Foods and H.J. Heinz Company. He began his career in the consumer products industry as a consultant with Booz Allen & Hamilton, where he advanced to partner in the firm's consumer practice. Mr. Hsu also serves on the board of directors of McDonald's.
Nelson Urdaneta, Chief Financial Officer & Senior Vice President
Nelson Urdaneta was appointed Chief Financial Officer of Kimberly-Clark, effective April 22, 2022. Prior to joining Kimberly-Clark, Mr. Urdaneta spent nearly 17 years at Mondelēz International. During his tenure at Mondelēz, he held various positions of increasing responsibility across multiple geographies, including Treasurer, Corporate Controller and Chief Accounting Officer, Chief Financial Officer of Asia Pacific, Supply Chain Finance leader for North America, and General Manager of Venezuela. Before Mondelēz, he held financial planning and analysis and supply chain pricing positions at Ryder System, Inc. He also served as a board member of Mondelēz's publicly traded joint ventures, JDE Peet's N.V. and Keurig Dr. Pepper Inc.
Russ Torres, President and Chief Operating Officer
Russ Torres was promoted to President and Chief Operating Officer of Kimberly-Clark in May 2025. In this role, he is responsible for the day-to-day operations of Kimberly-Clark's business segments, as well as the Global Supply Chain, Research & Development, Global Growth, and Digital Technology Solutions organizations. Mr. Torres joined Kimberly-Clark in 2020 as president of Kimberly-Clark's Professional business. Before his current appointment, he served as President of Kimberly-Clark's North America business.
Patricia Corsi, Chief Growth Officer
Patricia Corsi joined Kimberly-Clark as Chief Growth Officer, effective July 1, 2024. In this role, she oversees growth-centric brand and commercial capabilities, including global marketing, innovation, creative storytelling, design, insights & analytics, and revenue growth management. Prior to Kimberly-Clark, Ms. Corsi served as Chief Marketing, IT and Digital Officer at Bayer Consumer Health. She has also held leadership positions at Unilever and Heineken. Ms. Corsi is also a non-executive director at Tate & Lyle PLC.
Stacey Valy Panayiotou, Chief Human Resources Officer
Stacey Valy Panayiotou was appointed Chief Human Resources Officer of Kimberly-Clark, effective September 10, 2025. She is responsible for the global human resources function, including talent recruiting, development and performance management, labor relations, compensation, and employee benefits. Ms. Panayiotou joined Kimberly-Clark from Ball Corporation, where she most recently served as Chief Human Resources Officer, leading the end-to-end global function. Prior to Ball Corporation, she held several senior human resources leadership roles with global responsibility, including EVP and Chief Human Resources Officer at Graphic Packaging International and Global Vice President and Head of Talent and Development at The Coca-Cola Company.
AI Analysis | Feedback
Key Risks to Kimberly-Clark (KMB)
- Commodity Cost Volatility and Supply Chain Disruptions: Kimberly-Clark faces significant exposure to fluctuating raw material costs, such as wood pulp and polymer resins, as well as energy and logistics inflation. These cost volatilities can pressure margins and impact pricing power. The company's global operations also make it susceptible to supply chain disruptions, which can lead to increased costs and impede product delivery.
- Intense Competition and Shifting Consumer Preferences: The company operates in a highly competitive global market across its Personal Care, Consumer Tissue, and K-C Professional segments. Key rivals include Procter & Gamble, Unicharm, and Essity. Kimberly-Clark also faces increasing pressure from the growth of private-label alternatives and sustainable startups that can erode branded margins. Furthermore, changing consumer preferences, particularly a shift towards lower-priced options during inflationary periods and increased online shopping, can impact demand and market share.
- Softening Consumer Demand and Economic Headwinds: Kimberly-Clark is susceptible to a softening of consumer demand in various markets, particularly in international regions, influenced by economic pressures and inflation. There is evidence of a "bifurcated" consumer market where some consumers trade down to more affordable products. Additionally, declining birth rates in key markets such as China, South Korea, and the United States put pressure on the volume growth rates of its childcare products within the Personal Care segment.
AI Analysis | Feedback
- The growing consumer preference for reusable and sustainable alternatives across personal care and consumer tissue categories. This includes increased adoption of modern cloth diapers, menstrual cups, reusable period underwear, and reusable household cleaning products, directly threatening demand for Kimberly-Clark's core disposable product lines.
- The increasing market share captured by agile direct-to-consumer (DTC) brands and enhanced private labels, which often emphasize eco-friendliness, niche product features, and subscription models. These brands circumvent traditional retail channels and appeal to specific consumer segments, posing a challenge to Kimberly-Clark's established brand loyalty and distribution networks.
AI Analysis | Feedback
Kimberly-Clark Corporation (KMB) operates in several large addressable markets for its personal care, consumer tissue, and professional products. The market sizes for their main products and services are as follows:
- Baby Diapers: The global baby diapers market was estimated at USD 83.31 billion in 2025 and is projected to reach USD 141.80 billion by 2033. Another estimate places the global diaper market size at USD 80.90 billion in 2025, growing to USD 108.17 billion by 2034. The disposable baby diaper market alone was valued at USD 40.89 billion in 2026 and is expected to reach USD 47.92 billion by 2035 globally.
- Baby Wipes: The global baby wipes market size was estimated at USD 5.91 billion in 2024 and is projected to reach USD 7.99 billion by 2030. Another report estimates the global baby wipes market to be USD 6.2 billion in 2025, projected to reach USD 9.1 billion by 2035.
- Feminine Hygiene Products: The global feminine hygiene products market size was valued at USD 48.96 billion in 2025 and is predicted to increase to approximately USD 101.80 billion by 2035. Another source indicates the global feminine hygiene products market size was USD 45.56 billion in 2025 and is anticipated to grow to USD 85.81 billion by 2036.
- Adult Incontinence Products: The global adult incontinence products market size was estimated at USD 16.4 billion in 2024 and is expected to grow to USD 27.4 billion by 2034. Another estimate values the global adult incontinence products market at USD 17 billion in 2025, projected to grow to USD 27 billion by 2034. The disposable incontinence products market was estimated at USD 15.46 billion in 2025 and is predicted to increase to approximately USD 30.81 billion by 2035.
- Facial Tissue: The global facial tissues market size was estimated at USD 8.04 billion in 2024 and is projected to reach USD 10.28 billion by 2030. Other data suggests the global facial tissue market size was valued at USD 13.2 billion in 2023 and is expected to reach USD 27.8 billion by 2032. Another report indicates the global facial tissue paper market size was valued at USD 5.87 billion in 2024, projected to reach USD 7.35 billion by 2034.
- Bathroom Tissue (Toilet Paper): The global toilet paper market size was estimated at USD 56.36 billion in 2024 and is projected to grow to USD 79.53 billion by 2033. Another report states the global bath & toilet tissue market size was valued at USD 33.56 billion in 2025 and is projected to reach USD 61.04 billion by 2034.
- Paper Towels: The global paper towels market size was estimated at USD 15.2 billion in 2024 and is projected to reach USD 22.95 billion by 2035. Other estimates place the global paper towels market size at USD 17.63 billion in 2025, poised to grow to USD 28.17 billion by 2035.
- Professional/Away-From-Home (AFH) Hygiene Products: The global professional hygiene market size was USD 17.4 billion in 2024 and is predicted to reach USD 26.4 billion by 2032. Another source states the global professional hygiene market was valued at USD 17.80 billion in 2024, projected to reach USD 25.02 billion by 2030. The global away-from-home tissue and hygiene market size was valued at USD 45.18 billion in 2024 and is predicted to grow to USD 91.90 billion by 2034. North America held the largest share of the away-from-home tissue and hygiene market with 42.7% and a value of USD 18.1 billion in 2025.
AI Analysis | Feedback
Kimberly-Clark Corporation (KMB) is expected to drive future revenue growth over the next two to three years through several strategic initiatives:- Organic Sales Growth through Price, Mix, and Volume: Kimberly-Clark anticipates continued organic net sales growth, driven by a balanced contribution from price realization, favorable product mix, and increasing volumes. This approach emphasizes healthier top-line momentum. For instance, the company expected a mid-single-digit percentage increase in 2024 Organic Net Sales, an upward revision from earlier forecasts. Pricing, particularly in hyperinflationary economies, and volume growth, spurred by innovation and improved supply, are key components of this strategy.
- Product Innovation and Premiumization: The company is focused on "pioneering innovation" to enhance the value proposition of its global brands and "elevate categories". This strategy involves making products better across the board and premiumizing offerings to drive demand. Kimberly-Clark plans to increase advertising spending and innovate further to drive growth.
- Strategic Market Expansion and Share Gains: Kimberly-Clark aims to expand its market presence and gain share in key regions and high-growth categories. The Personal Care segment is consistently highlighted as a strong revenue engine, with broad-based growth across regions and strong performance in markets like North America and China. The company has shown consistent double-digit growth in China over the past five years and is gaining market share in a fragmented category.
- Portfolio Optimization and Focus on Core Brands: Kimberly-Clark is strategically managing its portfolio by divesting non-core businesses to concentrate on higher-margin, branded products. Examples include the divestiture of the Brazil Tissue business and plans to exit certain private label diaper businesses in the U.S. to focus on proprietary, science-based innovation. This shift, while potentially causing short-term reported net sales headwinds, is intended to drive long-term profitable organic growth.
- Productivity Savings and Reinvestment in Brands: While not a direct revenue driver, the company's commitment to achieving significant productivity savings (e.g., $3 billion over several years) is crucial. These savings enhance profitability and allow Kimberly-Clark to reinvest in its brands, innovation pipeline, and commercial capabilities, which are fundamental to sustaining future revenue growth and competitive advantage.
AI Analysis | Feedback
Share Repurchases
- Kimberly-Clark repurchased 1.1 million shares at a cost of $141 million in 2025.
- In 2024, the company completed share repurchases of 7.2 million shares for $1.0 billion.
- Kimberly-Clark completed $225 million in share repurchases in 2023.
Share Issuance
- Kimberly-Clark stockholders approved the issuance of common stock to Kenvue stockholders in connection with a planned two-step merger on January 29, 2026. Approximately 96% of shares present at the meeting, totaling 239,054,286 votes, favored the issuance.
Outbound Investments
- Kimberly-Clark announced an agreement on November 3, 2025, to acquire all outstanding shares of Kenvue Inc. in a cash and stock transaction valued at approximately $48.7 billion.
- The company is in the process of selling its International Family Care and Professional (IFP) business, including a 51% ownership stake for $1.7 billion, with the transaction expected to close in mid-2026.
- In the first quarter of 2022, Kimberly-Clark acquired a controlling interest in Thinx.
Capital Expenditures
- Capital spending was $1.1 billion in 2025, a notable increase from $721 million in 2024.
- Capital expenditures were $721 million in 2024, following $766 million in 2023, $876 million in 2022, and $1.007 billion in 2021.
- Kimberly-Clark anticipates capital spending of approximately $1.3 billion in 2026, which includes investments related to its 2024 Transformation Initiative aimed at innovation, margin optimization, and organizational growth.
Latest Trefis Analyses
Trade Ideas
Select ideas related to KMB.
| Date | Ticker | Company | Category | Trade Strategy | 6M Fwd Rtn | 12M Fwd Rtn | 12M Max DD |
|---|---|---|---|---|---|---|---|
| 03272026 | MZTI | Marzetti | Dip Buy | DB | FCFY OPMDip Buy with High FCF Yield and High MarginBuying dips for companies with high FCF yield and meaningfully high operating margin | 0.9% | 0.9% | 0.0% |
| 03272026 | TAP | Molson Coors Beverage | Dip Buy | DB | FCFY OPMDip Buy with High FCF Yield and High MarginBuying dips for companies with high FCF yield and meaningfully high operating margin | -0.8% | -0.8% | -1.1% |
| 03202026 | KHC | Kraft Heinz | Dip Buy | DB | FCFY OPMDip Buy with High FCF Yield and High MarginBuying dips for companies with high FCF yield and meaningfully high operating margin | 4.3% | 4.3% | -1.7% |
| 03202026 | KMB | Kimberly-Clark | Dip Buy | DB | FCFY OPMDip Buy with High FCF Yield and High MarginBuying dips for companies with high FCF yield and meaningfully high operating margin | -1.8% | -1.8% | -1.9% |
| 03202026 | MKC | McCormick | Dip Buy | DB | P/E OPMDip Buy with Low PE and High MarginBuying dips for companies with tame PE and meaningfully high operating margin | -5.2% | -5.2% | -5.2% |
Research & Analysis
Invest in Strategies
Wealth Management
Peer Comparisons
| Peers to compare with: |
Financials
| Median | |
|---|---|
| Name | |
| Mkt Price | 95.60 |
| Mkt Cap | 27.3 |
| Rev LTM | 11,996 |
| Op Inc LTM | 1,783 |
| FCF LTM | 1,366 |
| FCF 3Y Avg | 1,634 |
| CFO LTM | 1,996 |
| CFO 3Y Avg | 2,159 |
Growth & Margins
| Median | |
|---|---|
| Name | |
| Rev Chg LTM | 0.3% |
| Rev Chg 3Y Avg | 1.0% |
| Rev Chg Q | 1.7% |
| QoQ Delta Rev Chg LTM | 0.4% |
| Op Mgn LTM | 16.2% |
| Op Mgn 3Y Avg | 16.8% |
| QoQ Delta Op Mgn LTM | -0.3% |
| CFO/Rev LTM | 17.9% |
| CFO/Rev 3Y Avg | 18.5% |
| FCF/Rev LTM | 14.5% |
| FCF/Rev 3Y Avg | 14.6% |
Valuation
| Median | |
|---|---|
| Name | |
| Mkt Cap | 27.3 |
| P/S | 2.6 |
| P/EBIT | 16.0 |
| P/E | 18.8 |
| P/CFO | 14.7 |
| Total Yield | 5.3% |
| Dividend Yield | 2.3% |
| FCF Yield 3Y Avg | 4.8% |
| D/E | 0.2 |
| Net D/E | 0.2 |
Returns
| Median | |
|---|---|
| Name | |
| 1M Rtn | -6.7% |
| 3M Rtn | 8.7% |
| 6M Rtn | 2.1% |
| 12M Rtn | -12.7% |
| 3Y Rtn | -8.7% |
| 1M Excs Rtn | -6.5% |
| 3M Excs Rtn | 10.7% |
| 6M Excs Rtn | 1.6% |
| 12M Excs Rtn | -50.5% |
| 3Y Excs Rtn | -71.9% |
Comparison Analyses
Segment Financials
Revenue by Segment| $ Mil | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|
| Baby and Child Care | 7,054 | ||||
| Family Care | 6,290 | ||||
| Professional | 3,404 | ||||
| Adult Care | 1,809 | ||||
| Feminine Care | 1,787 | ||||
| All Other | 87 | ||||
| Consumer Tissue | 6,243 | 6,034 | 6,718 | 5,993 | |
| Corporate & Other | 54 | 67 | 64 | 57 | |
| Kimberly-Clark (K-C) Professional | 3,256 | 3,072 | 3,019 | 3,292 | |
| Personal Care | 10,622 | 10,267 | 9,339 | 9,108 | |
| Total | 20,431 | 20,175 | 19,440 | 19,140 | 18,450 |
Price Behavior
| Market Price | $97.00 | |
| Market Cap ($ Bil) | 32.2 | |
| First Trading Date | 12/17/1984 | |
| Distance from 52W High | -29.6% | |
| 50 Days | 200 Days | |
| DMA Price | $101.89 | $111.43 |
| DMA Trend | down | indeterminate |
| Distance from DMA | -4.8% | -12.9% |
| 3M | 1YR | |
| Volatility | 24.3% | 25.1% |
| Downside Capture | -0.00 | 0.06 |
| Upside Capture | 4.39 | -21.60 |
| Correlation (SPY) | -2.3% | 2.9% |
| 1M | 2M | 3M | 6M | 1Y | 3Y | |
|---|---|---|---|---|---|---|
| Beta | 0.52 | 0.15 | -0.09 | -0.15 | 0.10 | 0.09 |
| Up Beta | 1.68 | 0.37 | -0.15 | 0.62 | 0.22 | 0.23 |
| Down Beta | 0.15 | 0.51 | 0.01 | -0.09 | 0.07 | -0.10 |
| Up Capture | 5% | 7% | -16% | -48% | -11% | 1% |
| Bmk +ve Days | 7 | 16 | 27 | 65 | 139 | 424 |
| Stock +ve Days | 9 | 25 | 35 | 61 | 116 | 393 |
| Down Capture | 103% | -4% | -9% | -15% | 21% | 29% |
| Bmk -ve Days | 12 | 23 | 33 | 58 | 110 | 323 |
| Stock -ve Days | 13 | 17 | 28 | 65 | 136 | 358 |
[1] Upside and downside betas calculated using positive and negative benchmark daily returns respectively
Based On 1-Year Data
| Annualized Return | Annualized Volatility | Sharpe Ratio | Correlation with KMB | |
|---|---|---|---|---|
| KMB | -26.6% | 25.2% | -1.26 | - |
| Sector ETF (XLP) | 7.8% | 13.4% | 0.32 | 54.5% |
| Equity (SPY) | 28.9% | 17.3% | 1.35 | 3.3% |
| Gold (GLD) | 56.6% | 27.9% | 1.61 | 11.3% |
| Commodities (DBC) | 24.9% | 16.8% | 1.29 | -10.9% |
| Real Estate (VNQ) | 13.8% | 15.6% | 0.63 | 29.2% |
| Bitcoin (BTCUSD) | -14.5% | 44.2% | -0.23 | -2.4% |
Smart multi-asset allocation framework can stack odds in your favor. Learn How
Based On 5-Year Data
| Annualized Return | Annualized Volatility | Sharpe Ratio | Correlation with KMB | |
|---|---|---|---|---|
| KMB | -3.4% | 19.9% | -0.25 | - |
| Sector ETF (XLP) | 6.6% | 13.2% | 0.28 | 62.3% |
| Equity (SPY) | 11.6% | 17.0% | 0.53 | 17.6% |
| Gold (GLD) | 22.3% | 17.8% | 1.03 | 6.7% |
| Commodities (DBC) | 11.8% | 18.8% | 0.52 | -8.8% |
| Real Estate (VNQ) | 3.9% | 18.8% | 0.11 | 32.6% |
| Bitcoin (BTCUSD) | 4.0% | 56.5% | 0.29 | 1.5% |
Smart multi-asset allocation framework can stack odds in your favor. Learn How
Based On 10-Year Data
| Annualized Return | Annualized Volatility | Sharpe Ratio | Correlation with KMB | |
|---|---|---|---|---|
| KMB | 0.1% | 20.9% | -0.02 | - |
| Sector ETF (XLP) | 7.3% | 14.7% | 0.36 | 67.6% |
| Equity (SPY) | 13.9% | 17.9% | 0.67 | 33.0% |
| Gold (GLD) | 14.1% | 15.9% | 0.74 | 6.7% |
| Commodities (DBC) | 8.4% | 17.6% | 0.40 | 1.6% |
| Real Estate (VNQ) | 5.1% | 20.7% | 0.21 | 40.8% |
| Bitcoin (BTCUSD) | 67.4% | 66.9% | 1.07 | 1.5% |
Smart multi-asset allocation framework can stack odds in your favor. Learn How
Returns Analyses
Earnings Returns History
Expand for More| Forward Returns | |||
|---|---|---|---|
| Earnings Date | 1D Returns | 5D Returns | 21D Returns |
| 1/27/2026 | -0.5% | -1.6% | 8.0% |
| 10/30/2025 | 3.0% | -14.3% | -7.0% |
| 8/1/2025 | 4.8% | 9.7% | 3.6% |
| 4/22/2025 | -1.5% | -6.5% | 1.1% |
| 1/28/2025 | -1.5% | -0.7% | 5.9% |
| 10/22/2024 | -4.5% | -6.0% | -6.0% |
| 7/23/2024 | -5.7% | -2.3% | 0.1% |
| 4/23/2024 | 5.5% | 5.4% | 3.7% |
| ... | |||
| SUMMARY STATS | |||
| # Positive | 11 | 9 | 12 |
| # Negative | 13 | 15 | 12 |
| Median Positive | 3.0% | 5.4% | 3.0% |
| Median Negative | -3.1% | -2.7% | -5.0% |
| Max Positive | 8.1% | 10.8% | 16.5% |
| Max Negative | -6.9% | -14.3% | -7.9% |
SEC Filings
Expand for More| Report Date | Filing Date | Filing |
|---|---|---|
| 12/31/2025 | 02/12/2026 | 10-K |
| 09/30/2025 | 10/30/2025 | 10-Q |
| 06/30/2025 | 08/01/2025 | 10-Q |
| 03/31/2025 | 04/22/2025 | 10-Q |
| 12/31/2024 | 02/13/2025 | 10-K |
| 09/30/2024 | 10/22/2024 | 10-Q |
| 06/30/2024 | 07/23/2024 | 10-Q |
| 03/31/2024 | 04/23/2024 | 10-Q |
| 12/31/2023 | 02/08/2024 | 10-K |
| 09/30/2023 | 10/24/2023 | 10-Q |
| 06/30/2023 | 07/25/2023 | 10-Q |
| 03/31/2023 | 04/25/2023 | 10-Q |
| 12/31/2022 | 02/09/2023 | 10-K |
| 09/30/2022 | 10/25/2022 | 10-Q |
| 06/30/2022 | 07/26/2022 | 10-Q |
| 03/31/2022 | 04/22/2022 | 10-Q |
Recent Forward Guidance [BETA]
Latest: Q4 2025 Earnings Reported 1/27/2026
| Forward Guidance | Guidance Change | ||||||
|---|---|---|---|---|---|---|---|
| Metric | Low | Mid | High | % Chg | % Delta | Change | Prior |
| 2026 Revenue Growth | 2.0% | 0.0% | 0.0% | Affirmed | Guidance: 2.0% for 2025 | ||
| 2026 Adjusted Operating Profit Growth | 5.0% | 7.0% | 9.0% | 250.0% | 5.0% | Raised | Guidance: 2.0% for 2025 |
| 2026 EPS Growth | 10.0% | 185.7% | 6.5% | Raised | Guidance: 3.5% for 2025 | ||
| 2026 Income from Equity Companies Increase | 0.3 | Higher New | |||||
| 2026 Adjusted Effective Tax Rate | 23.0% | Higher New | |||||
Prior: Q3 2025 Earnings Reported 10/30/2025
| Forward Guidance | Guidance Change | ||||||
|---|---|---|---|---|---|---|---|
| Metric | Low | Mid | High | % Chg | % Delta | Change | Prior |
| 2025 Organic Sales Growth | 2.0% | Higher New | |||||
| 2025 Adjusted Operating Profit Growth | 2.0% | -42.9% | -1.5% | Lowered | Guidance: 3.5% for 2025 | ||
| 2025 Adjusted EPS Growth | 3.5% | 0 | 0.0% | Affirmed | Guidance: 3.5% for 2025 | ||
| 2025 Free Cash Flow | 2.00 Bil | 0 | Affirmed | Guidance: 2.00 Bil for 2025 | |||
Insider Activity
Expand for More| # | Owner | Title | Holding | Action | Filing Date | Price | Shares | Transacted Value | Value of Held Shares | Form |
|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Hicks, Zackery A | Chief Digital & Technology Off | Direct | Sell | 8042025 | 133.40 | 15,038 | 2,006,117 | 1,910,467 | Form |
| 2 | Chen, Katy | President, Int'l Personal Care | Direct | Sell | 5022025 | 129.70 | 740 | 95,978 | 518,411 | Form |
| 3 | Chen, Katy | President, Int'l Personal Care | Direct | Sell | 4292025 | 130.74 | 1,794 | 234,545 | 405,028 | Form |
| 4 | Drexler, Andrew | Vice President and Controller | Direct | Sell | 3042025 | 141.00 | 10,838 | 1,528,158 | 1,088,520 | Form |
| 5 | Drexler, Andrew | Vice President and Controller | Direct | Sell | 2242025 | 140.00 | 2,500 | 350,000 | 357,420 | Form |
External Quote Links
| Y Finance | Barrons |
| TradingView | Morningstar |
| SeekingAlpha | ValueLine |
| Motley Fool | Robinhood |
| CNBC | Etrade |
| MarketWatch | Unusual Whales |
| YCharts | Perplexity Finance |
| FinViz |
Prefer one of these to Trefis? Tell us why.